Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kyntra Bio (KYNB) Restructuring Costs (2023 - 2025)

Historic Restructuring Costs for Kyntra Bio (KYNB) over the last 3 years, with Q3 2025 value amounting to $41000.0.

  • Kyntra Bio's Restructuring Costs fell 9977.9% to $41000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 9188.32%. This contributed to the annual value of $19.5 million for FY2024, which is 5468.82% up from last year.
  • Per Kyntra Bio's latest filing, its Restructuring Costs stood at $41000.0 for Q3 2025, which was down 9977.9% from $393000.0 recorded in Q2 2025.
  • In the past 5 years, Kyntra Bio's Restructuring Costs ranged from a high of $18.6 million in Q3 2024 and a low of $41000.0 during Q3 2025
  • For the 3-year period, Kyntra Bio's Restructuring Costs averaged around $5.4 million, with its median value being $669500.0 (2024).
  • Per our database at Business Quant, Kyntra Bio's Restructuring Costs skyrocketed by 4718.39% in 2024 and then crashed by 9977.9% in 2025.
  • Quarter analysis of 3 years shows Kyntra Bio's Restructuring Costs stood at $12.6 million in 2023, then tumbled by 92.5% to $946000.0 in 2024, then tumbled by 95.67% to $41000.0 in 2025.
  • Its Restructuring Costs stands at $41000.0 for Q3 2025, versus $393000.0 for Q2 2025 and $126000.0 for Q1 2025.